Literature DB >> 9783344

Selective attention in schizophrenia: relationship to verbal working memory.

D M Barch1, C S Carter.   

Abstract

In previous work using the Stroop task to examine cognitive function in schizophrenia, we have suggested that reaction time (RT) facilitation and error interference should be more sensitive measures of cognitive function than RT interference. We examined this hypothesis in 36 DSM-IV schizophrenia and schizoaffective patients, who performed both the Stroop and the Speaking Span, a measure of verbal working memory. The results supported our hypotheses, demonstrating that RT facilitation and error interference were associated more strongly with working memory performance than RT interference. The robust correlations between these measures of selective attention and Speaking Span performance has implications for understanding the nature and selectivity of cognitive dysfunction in schizophrenia. We present several different hypotheses that may explain this relationship, including: (1) a generalized deficit; (2) a common cognitive disturbance; and (3) a common neurobiological dysfunction.

Entities:  

Mesh:

Year:  1998        PMID: 9783344     DOI: 10.1016/s0920-9964(98)00064-4

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

1.  Spatial attentional control is not impaired in schizophrenia: Dissociating specific deficits from generalized impairments.

Authors:  Ansam A Elshaikh; Scott R Sponheim; Matt V Chafee; Angus W MacDonald
Journal:  J Abnorm Psychol       Date:  2014-12-29

2.  Influence of empathetic pain processing on cognition in schizophrenia.

Authors:  Kesong Hu; Marijn Lijffijt; Theodore P Beauchaine; Zhiwei Fan; Hui Shi; Shuchang He
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-12-05       Impact factor: 5.270

3.  Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo.

Authors:  Garry D Honey; Philip R Corlett; Anthony R Absalom; Michael Lee; Edith Pomarol-Clotet; Graham K Murray; Peter J McKenna; Edward T Bullmore; David K Menon; Paul C Fletcher
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

Review 4.  Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.

Authors:  José A Apud; Daniel R Weinberger
Journal:  NeuroRx       Date:  2006-01

Review 5.  When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia.

Authors:  R Alison Adcock; Corby Dale; Melissa Fisher; Stephanie Aldebot; Alexander Genevsky; Gregory V Simpson; Srikantan Nagarajan; Sophia Vinogradov
Journal:  Schizophr Bull       Date:  2009-09-10       Impact factor: 9.306

6.  Persistence, diagnostic specificity and genetic liability for context-processing deficits in schizophrenia.

Authors:  Annette E Richard; Cameron S Carter; Jonathan D Cohen; Raymond Y Cho
Journal:  Schizophr Res       Date:  2013-04-06       Impact factor: 4.939

7.  Dopamine in socioecological and evolutionary perspectives: implications for psychiatric disorders.

Authors:  Yoshie Yamaguchi; Young-A Lee; Yukiori Goto
Journal:  Front Neurosci       Date:  2015-06-16       Impact factor: 4.677

8.  Region specific knockdown of Parvalbumin or Somatostatin produces neuronal and behavioral deficits consistent with those observed in schizophrenia.

Authors:  Stephanie M Perez; Angela Boley; Daniel J Lodge
Journal:  Transl Psychiatry       Date:  2019-10-21       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.